Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Bouffet

Showing results (11-20 of 532) with videos related to

Pageof 54
Sort By:
Neuro-Oncology|April 1, 2020
Neuro-oncology in adolescents and young adults-an unmet needJulie Bennett, Eric Bouffet
Expert Opinion on Emerging Drugs|January 31, 2024
How will tovorafenib change our treatment of pediatric low-grade glioma?Inci Yaman, Eric Bouffet
Neuro-Oncology Advances|April 30, 2026
From blunt tools to bullseyes: The impact of targeted therapy in pediatric neuro-oncologyJulie Bennett, Eric Bouffet
The Lancet. Oncology|June 15, 2016
Proton beam therapy for medulloblastomaVijay Ramaswamy, Eric Bouffet
Neuro-Oncology|March 11, 2021
Brainstem gliomas … the devil is in the detailsAdriana Fonseca, Eric Bouffet
Neuro-Oncology Advances|May 15, 2026
The future of targeted therapies for pediatric central nervous system tumorsHolly Lindsay, Eric Bouffet
Neuro-Oncology|June 24, 2022
BRAF inhibitors in BRAFV600E-mutated pediatric high-grade gliomas: Upfront or at recurrence?Liana Nobre, Eric Bouffet
Neuro-Oncology|September 25, 2016
Old chemotherapy makes a comeback: dual alkylator therapy for pediatric high-grade gliomaEric Bouffet, Vijay Ramaswamy
Journal of Neuro-Oncology|August 6, 2025
Summary of the collection on 'immunotherapy in pediatric brain tumors-an update'Soumen Khatua, Eric Bouffet
Current Neurology and Neuroscience Reports|August 14, 2024
Advances in the Treatment of Pediatric Low-Grade GliomasInci Yaman Bajin, Eric Bouffet
Pageof 54

Showing results (11-20 of 532) with videos related to

Sort By:
Pageof 54
Neuro-Oncology|April 1, 2020
Neuro-oncology in adolescents and young adults-an unmet needJulie Bennett, Eric Bouffet
Expert Opinion on Emerging Drugs|January 31, 2024
How will tovorafenib change our treatment of pediatric low-grade glioma?Inci Yaman, Eric Bouffet
Neuro-Oncology Advances|April 30, 2026
From blunt tools to bullseyes: The impact of targeted therapy in pediatric neuro-oncologyJulie Bennett, Eric Bouffet
The Lancet. Oncology|June 15, 2016
Proton beam therapy for medulloblastomaVijay Ramaswamy, Eric Bouffet
Neuro-Oncology|March 11, 2021
Brainstem gliomas … the devil is in the detailsAdriana Fonseca, Eric Bouffet
Neuro-Oncology Advances|May 15, 2026
The future of targeted therapies for pediatric central nervous system tumorsHolly Lindsay, Eric Bouffet
Neuro-Oncology|June 24, 2022
BRAF inhibitors in BRAFV600E-mutated pediatric high-grade gliomas: Upfront or at recurrence?Liana Nobre, Eric Bouffet
Neuro-Oncology|September 25, 2016
Old chemotherapy makes a comeback: dual alkylator therapy for pediatric high-grade gliomaEric Bouffet, Vijay Ramaswamy
Journal of Neuro-Oncology|August 6, 2025
Summary of the collection on 'immunotherapy in pediatric brain tumors-an update'Soumen Khatua, Eric Bouffet
Current Neurology and Neuroscience Reports|August 14, 2024
Advances in the Treatment of Pediatric Low-Grade GliomasInci Yaman Bajin, Eric Bouffet
Pageof 54